Drug Trial Radar · NCT06905873
A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Non-segmental Vitiligo
Last checked: Nov 19, 2026Latest source record: Oct 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
64
Planned (sponsor's estimate)
Start
Mar 25, 2025
Primary completion
Dec 31, 2026
Study completion Dec 31, 2026
Sponsor
- Lead sponsor
- Forte Biosciences, Inc.Industry
- Sponsor type
- Industry
- First posted
- Apr 2, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Randomized, Double-Blind, Placebo Controlled, Multi-center Study to Evaluate the Safety and Efficacy of FB102 in Patients with Non-Segmental Vitiligo.
Conditions
- Vitiligo
Interventions
FB102Drug
Route of administration- Intravenous (IV)
PlaceboDrug
Route of administration- Intravenous (IV)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants with treatment-emergent adverse events (TEAEs) and Serious Adverse events (SAE) following treatment with FB102Time frame: Upto 16 Weeks post first dose administration
- Percent change from Baseline in central read facial-vitiligo area scoring index (F-VASI)Time frame: Upto 16 Weeks post first dose administration
- Number of participants with percent change from Baseline in central read facial-vitiligo area scoring index (F-VASI)Time frame: Upto 16 Weeks post first dose administration
Locations
6 sites in 2 countries. Site status is shown where the registry gives one.
Skin & Cancer Foundation Australia - The Skin Hospital
Darlinghurst, New South Wales, Australia
Novatrials
Kotara, New South Wales, Australia
Cornerstone Dermatology
Coorparoo, Queensland, Australia
Optimal Clinical Trials North
Auckland, Auckland, New Zealand
Optimal Clinical Trials Central
Auckland, Auckland, New Zealand
Momentum Pukehoke
Auckland, Auckland, New Zealand
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.